Cargando…

The ethics of COVID-19 clinical trials: New considerations in a controversial area

Detalles Bibliográficos
Autores principales: Han, Zhenzhen, Wang, Junting, Zhang, Kai, Tang, Qilin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227522/
https://www.ncbi.nlm.nih.gov/pubmed/32426222
http://dx.doi.org/10.1016/j.imr.2020.100425
_version_ 1783534513729568768
author Han, Zhenzhen
Wang, Junting
Zhang, Kai
Tang, Qilin
author_facet Han, Zhenzhen
Wang, Junting
Zhang, Kai
Tang, Qilin
author_sort Han, Zhenzhen
collection PubMed
description
format Online
Article
Text
id pubmed-7227522
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-72275222020-05-18 The ethics of COVID-19 clinical trials: New considerations in a controversial area Han, Zhenzhen Wang, Junting Zhang, Kai Tang, Qilin Integr Med Res Editorial Elsevier 2020-09 2020-05-15 /pmc/articles/PMC7227522/ /pubmed/32426222 http://dx.doi.org/10.1016/j.imr.2020.100425 Text en © 2020 Korea Institute of Oriental Medicine. Publishing services by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Editorial
Han, Zhenzhen
Wang, Junting
Zhang, Kai
Tang, Qilin
The ethics of COVID-19 clinical trials: New considerations in a controversial area
title The ethics of COVID-19 clinical trials: New considerations in a controversial area
title_full The ethics of COVID-19 clinical trials: New considerations in a controversial area
title_fullStr The ethics of COVID-19 clinical trials: New considerations in a controversial area
title_full_unstemmed The ethics of COVID-19 clinical trials: New considerations in a controversial area
title_short The ethics of COVID-19 clinical trials: New considerations in a controversial area
title_sort ethics of covid-19 clinical trials: new considerations in a controversial area
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227522/
https://www.ncbi.nlm.nih.gov/pubmed/32426222
http://dx.doi.org/10.1016/j.imr.2020.100425
work_keys_str_mv AT hanzhenzhen theethicsofcovid19clinicaltrialsnewconsiderationsinacontroversialarea
AT wangjunting theethicsofcovid19clinicaltrialsnewconsiderationsinacontroversialarea
AT zhangkai theethicsofcovid19clinicaltrialsnewconsiderationsinacontroversialarea
AT tangqilin theethicsofcovid19clinicaltrialsnewconsiderationsinacontroversialarea
AT hanzhenzhen ethicsofcovid19clinicaltrialsnewconsiderationsinacontroversialarea
AT wangjunting ethicsofcovid19clinicaltrialsnewconsiderationsinacontroversialarea
AT zhangkai ethicsofcovid19clinicaltrialsnewconsiderationsinacontroversialarea
AT tangqilin ethicsofcovid19clinicaltrialsnewconsiderationsinacontroversialarea